Moving Towards PDE6A Gene Supplementation Therapy.

doi:10.1001/jamaophthalmol.2020.4216

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Moving Towards PDE6A Gene Supplementation Therapy.

JAMA ophthalmology - 1 Dec 2020

Bujakowska Kinga M, Comander Jason

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclic Nucleotide Phosphodiesterases, Type 6
Share to Dietary Supplements
Share to Eye Proteins
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Retinitis Pigmentosa

Source

Open in PubMed Open full text

Identifiers

PMID: 33057571
DOI: 10.1001/jamaophthalmol.2020.4216
PMCID: PMC8168273

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Moving Towards PDE6A Gene Supplementation Therapy.PMID 33057571Read ↗

Identification and Regulation of Human PDE5A Gene PromoterSemantic proximity Read ↗

Perspective on the future use of genomics in exercise prescription.Semantic proximity Read ↗

Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trialSemantic proximity Read ↗

Human PDE5A gene encodes three PDE5 isoforms from two alternate promotersSemantic proximity Read ↗

Gene therapy as future treatment of erectile dysfunctionSemantic proximity Read ↗

Towards gene therapy to enhance apolipoprotein AI expression.Semantic proximity Read ↗

Splice-inhibition therapy targets progeria.Semantic proximity Read ↗

Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European UnionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.